Gastrobody Therapeutics
PrivateLast Round
Grant
Nov 20, 2025
Total Funding Raised
$1.26M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Gastrobody Therapeutics is a biotechnology company developing ultrastable, orally-administered protein therapeutics to treat conditions of the gastrointestinal tract.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gastrobody Therapeutics Comparables
Compare Gastrobody Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Plantibodies | 86% | |
| Sorriso Pharmaceuticals | 86% | |
| Fzata, Inc. | 80% | |
Gastrobody Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 20, 2025 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 20, 2025
$1.26M grant received from Technology Investment Fund and Wellcome Trust.
Gastrobody Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gastrobody Therapeutics's valuation, stock price, and market status.